Member of the Association of American Physicians
John F. DiPersio focuses on Internal medicine, Transplantation, Immunology, Leukemia and Stem cell. His Internal medicine research is multidisciplinary, incorporating elements of Gastroenterology, Endocrinology, Surgery and Oncology. His Transplantation study combines topics in areas such as Plerixafor, Survival analysis and Granulocyte colony-stimulating factor.
His research on Immunology often connects related areas such as Cancer research. The concepts of his Leukemia study are interwoven with issues in Myeloid, Myeloid leukemia, Chemotherapy and Somatic evolution in cancer. His Myeloid leukemia study combines topics from a wide range of disciplines, such as Genetics, Mutation, Clonal architecture, Molecular biology and Comparative genomic hybridization.
His main research concerns Internal medicine, Transplantation, Immunology, Oncology and Surgery. As part of the same scientific family, John F. DiPersio usually focuses on Internal medicine, concentrating on Gastroenterology and intersecting with Toxicity. His research in Transplantation focuses on subjects like Plerixafor, which are connected to Hematopoietic Stem Cell Mobilization and Multiple myeloma.
John F. DiPersio interconnects Progenitor cell, Haematopoiesis and Stem cell in the investigation of issues within Immunology. John F. DiPersio combines subjects such as Placebo and Cumulative incidence with his study of Surgery. His work is dedicated to discovering how Leukemia, Cancer research are connected with Immunotherapy and other disciplines.
His primary areas of study are Internal medicine, Cancer research, Transplantation, Oncology and Myeloid leukemia. His Internal medicine study frequently draws connections to other fields, such as Gastroenterology. His Cancer research research is multidisciplinary, incorporating perspectives in T cell, Antigen, Leukemia, CD3 and Immunotherapy.
His Transplantation study combines topics in areas such as Hematopoietic cell, Stem cell and Immunology. The study incorporates disciplines such as Myeloid, Complete remission, Disease and Refractory in addition to Oncology. The various areas that John F. DiPersio examines in his Myeloid leukemia study include Immune system and Bone marrow.
John F. DiPersio mainly investigates Internal medicine, Transplantation, Oncology, Myeloid leukemia and Immunology. His Gastroenterology research extends to Internal medicine, which is thematically connected. His Transplantation study necessitates a more in-depth grasp of Surgery.
His work carried out in the field of Myeloid leukemia brings together such families of science as Adverse effect and Cohort. His biological study spans a wide range of topics, including Haematopoiesis, Hematopoietic stem cell, Telomerase reverse transcriptase and Decitabine. His Leukemia research integrates issues from Cancer research and Refractory.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia
Timothy J. Ley;Christopher Miller;Li Ding;Benjamin J. Raphael.
The New England Journal of Medicine (2013)
Recurring mutations found by sequencing an acute myeloid leukemia genome.
Elaine R. Mardis;Li Ding;David J. Dooling;David E. Larson.
The New England Journal of Medicine (2009)
Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing
Li Ding;Timothy J. Ley;David E. Larson;Christopher A. Miller.
DNMT3A Mutations in Acute Myeloid Leukemia
Timothy J. Ley;Li Ding;Matthew J. Walter;Michael D. McLellan.
The New England Journal of Medicine (2010)
A Double-Blind, Placebo-Controlled Trial of Ruxolitinib for Myelofibrosis
Srdan Verstovsek;Ruben A. Mesa;Jason Gotlib;Richard S. Levy.
The New England Journal of Medicine (2012)
DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome
Timothy J. Ley;Elaine R. Mardis;Li Ding;Bob Fulton.
The Origin and Evolution of Mutations in Acute Myeloid Leukemia
John S. Welch;Timothy J. Ley;Daniel C. Link;Christopher A. Miller.
Age-related mutations associated with clonal hematopoietic expansion and malignancies
Mingchao Xie;Charles Lu;Jiayin Wang;Michael D McLellan.
Nature Medicine (2014)
A Phase 2 Trial of Ponatinib in Philadelphia Chromosome–Positive Leukemias
Jorge E. Cortes;D. W. Kim;J. Pinilla-Ibarz;P. Le Coutre.
The New England Journal of Medicine (2013)
Phase III prospective randomized double-blind placebo-controlled trial of plerixafor plus granulocyte colony-stimulating factor compared with placebo plus granulocyte colony-stimulating factor for autologous stem-cell mobilization and transplantation for patients with non-Hodgkin's lymphoma.
John F. DiPersio;Ivana N. Micallef;Patrick J. Stiff;Brian J. Bolwell.
Journal of Clinical Oncology (2009)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: